孕期接种2009年甲型H1N1流感疫苗对幼儿健康结局的影响
多数免疫相关、非免疫相关及非特异性 morbidity 结局与暴露无显著关联,仅观察到哮喘风险轻度升高和胃肠道感染率轻度降低,敏感性分析结果不变,作者认为残余混杂可能解释上述微弱关联。
要点
- 孕期接种pH1N1流感疫苗与多数5岁前儿童健康结局无显著关联。
- 哮喘风险轻度升高(aHR 1.05,95%CI 1.02–1.09),胃肠道感染率轻度降低(aIRR 0.94,95%CI 0.91–0.98)。
- 上述微弱关联可能由残余混杂解释,需未来研究进一步评估。
核心结论
- 孕期暴露于pH1N1流感疫苗与大多数5岁儿童健康结局无显著关联。
- 观察到哮喘风险轻度升高和胃肠道感染率轻度降低,但作者认为残余混杂可能解释这些微弱关联。
研究设计与样本
- 回顾性队列研究,基于加拿大安大略省人口出生登记与健康行政数据库链接。
- 采用倾向评分加权调整潜在混杂,评估风险比、发病率比和风险比。
主要发现
- 上呼吸道感染、下呼吸道感染、中耳炎、任何感染性疾病、肿瘤、感觉障碍、急诊或住院服务使用、儿科复杂慢性病及死亡率均无显著关联。
- 哮喘风险轻度升高(调整后风险比1.05,95%CI 1.02–1.09)。
- 胃肠道感染率轻度降低(调整后发病率比0.94,95%CI 0.91–0.98)。
- 敏感性分析中上述结果未改变。
临床怎么用
- 全科医生可向孕妇说明:孕期接种pH1N1流感疫苗与多数幼儿健康结局无显著关联。
- 对于哮喘和胃肠道感染的微弱关联,应结合残余混杂可能进行解释,避免过度解读。
局限性
- 观察性设计可能存在残余混杂。
- 作者指出哮喘和胃肠道感染关联应在未来研究中评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether any association exists between exposure to 2009 pandemic H1N1 (pH1N1) influenza vaccination during pregnancy and negative health outcomes in early childhood. DESIGN: Retrospective cohort study. SETTING: Population based birth registry linked with health administrative databases in the province of Ontario, Canada. PARTICIPANTS: All live births from November 2009 through October 2010 (n=104 249) were included, and children were followed until 5 years of age to ascertain study outcomes. MAIN OUTCOME MEASURES: Rates of immune related (infectious diseases, asthma), non-immune related (neoplasms, sensory disorders), and non-specific morbidity outcomes (urgent or inpatient health services use, pediatric complex chronic conditions) were evaluated from birth to 5 years of age; under-5 childhood mortality was also assessed. Propensity score weighting was used to adjust hazard ratios, incidence rate ratios, and risk ratios for potential confounding. RESULTS: Of 104 249 live births, 31 295 (30%) were exposed to pH1N1 influenza vaccination in utero. No significant associations were found with upper or lower respiratory infections, otitis media, any infectious diseases, neoplasms, sensory disorders, urgent and inpatient health services use, pediatric complex chronic conditions, or mortality. A weak association was observed between prenatal pH1N1 vaccination and increased risk of asthma (adjusted hazard ratio 1.05, 95% confidence interval 1.02 to 1.09) and decreased rates of gastrointestinal infections (adjusted incidence rate ratio 0.94, 0.91 to 0.98). These results were unchanged in sensitivity analyses accounting for any potential differential healthcare seeking behavior or access between exposure groups. CONCLUSIONS: No associations were observed between exposure to pH1N1 influenza vaccine during pregnancy and most five year pediatric health outcomes. Residual confounding may explain the small associations observed with increased asthma and reduced gastrointestinal infections. These outcomes should be assessed in future studies.
引用
- Walsh LK, Donelle J, Dodds L, et al. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. BMJ. 2019. PMID: 31292120. doi:10.1136/bmj.l4151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。